首页> Journal of clinical oncology : official journal of the American Society of Clinical Oncology> Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up.

Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up.

导出 OA

翻译打印收藏纠错

第一作者： Thomas,Martin

第一单位： UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.

作者： Thomas,Martin ^[1] ; Saad Z,Usmani ^[2] ; Jesus G,Berdeja ^[3] ; Mounzer,Agha ^[4] ; Adam D,Cohen ^[5] ; Parameswaran,Hari ^[6] ; David,Avigan ^[7] ; Abhinav,Deol ^[8] ; Myo,Htut ^[9] ; Alexander,Lesokhin ^[2] ; Nikhil C,Munshi ^[10] ; Elizabeth,O'Donnell ^[11] ; A Keith,Stewart ^[12] ; Jordan M,Schecter ^[13] ; Jenna D,Goldberg ^[13] ; Carolyn C,Jackson ^[13] ; Tzu-Min,Yeh ^[13] ; Arnob,Banerjee ^[14] ; Alicia,Allred ^[14] ; Enrique,Zudaire ^[14] ; William,Deraedt ^[15] ; Yunsi,Olyslager ^[15] ; Changwei,Zhou ^[16] ; Lida,Pacaud ^[16] ; Deepu,Madduri ^[13] ; Andrzej,Jakubowiak ^[17] ; Yi,Lin ^[18] ; Sundar,Jagannath ^[19]

作者单位： UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. ^[1] Memorial Sloan Kettering Cancer Center, New York, NY. ^[2] Sarah Cannon Research Institute, Nashville, TN. ^[3] UPMC Hillman Cancer Center, Pittsburgh, PA. ^[4] Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA. ^[5] Medical College of Wisconsin, Milwaukee, WI. ^[6] Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. ^[7] Karmanos Cancer Institute, Wayne State University, Detroit, MI. ^[8] City of Hope Comprehensive Cancer Center, Duarte, CA. ^[9] Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.;VA Boston Healthcare System, West Roxbury, MA. ^[10] Massachusetts General Hospital, Harvard Medical School, Boston, MA. ^[11] University Health Network and the Princess Margaret Cancer Centre, Toronto, ON, Canada. ^[12] Janssen R&D, Raritan, NJ. ^[13] Janssen R&D, Spring House, PA. ^[14] Janssen R&D, Beerse, Belgium. ^[15] Legend Biotech, Inc, Piscataway, NJ. ^[16] University of Chicago, Chicago, IL. ^[17] Mayo Clinic, Rochester, MN. ^[18] Mount Sinai Medical Center, New York, NY. ^[19]

医学主题词人类(Humans);B细胞成熟抗原(B-Cell Maturation Antigen);随访研究(Follow-Up Studies);免疫疗法, 过继(Immunotherapy, Adoptive);多发性骨髓瘤(Multiple Myeloma)

DOI 10.1200/JCO.22.00842

PMID 35658469

发布时间 2023-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交